Low Vitamin D Levels Linked to Parkinson’s Cognitive Impairment Risks

A recent study found that higher vitamin D levels were associate with better cognition in Parkinson patients. Among the Parkinson’s patients, average vitamin D levels were highest in those with normal cognition, followed by those with mild cognitive impairment, and then those with Parkinson’s disease dementia.

Read more about this research- https://parkinsonsnewstoday.com/2022/05/03/high-vitamin-d-levels-linked-fewer-cognitive-problems-study/

SOLIUS® devices are not cleared or approved for the indication to treat and/or prevent Parkinson's disease and/or other cognitive diseases or conditions. SOLIUS devices are intended only to stimulate the production of endogenous vitamin D for the treatment and prevention of vitamin D deficiency. Please review the important safety information associated with SOLIUS therapy.